Three Cases of Arterial Occlusion That Occurred After the Use of Angioseal(R)
Korean Circulation Journal
;
: 339-342, 2008.
Article
in English
| WPRIM
| ID: wpr-121053
ABSTRACT
Femoral arterial closure devices are now commonly used after both diagnostic and therapeutic coronary procedures. They have been shown to reduce the time to ambulation and to decrease the length of the hospital stay. Angioseal is a commercially available femoral artery closure device that has been approved by the Food and Drug Administration (FDA). The device sandwiches an intra-arterial absorbable anchor on the luminal side of the vessel and a thrombin plug on the surface of the vessel with using a self-cinching stitch. We report here on three patients who presented with acute and delayed arterial occlusive complications that were found to be due to an Angioseal anchor that was not appropriately reabsorbed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Phenobarbital
/
United States Food and Drug Administration
/
Thrombin
/
Walking
/
Femoral Artery
/
Glycosaminoglycans
/
Length of Stay
Limits:
Humans
Language:
English
Journal:
Korean Circulation Journal
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS